Who We Are
We are a medical device company developing light therapies for the 40 million people in the US with inflammatory skin disorders. Luma Therapeutics was born when our CEO Evan Anderson found that he had psoriasis and discovered a way to treat himself effectively. He knew then that he wanted to develop similar treatments for the millions of other people suffering from skin disorders.
We work hard every day to help people get clear skin with easy to use, affordable therapies.
Our goal is to develop an at home treatment that will put psoriasis in remission for an extended period of time after only a few weeks of therapy.
The Core team
Evan Anderson (CEO and Board Member) has 17 years of experience in early stage product and market development. He completed the Stanford Biodesign Fellowship in 2004 and was first manager of R&D and then distribution sales at Spiracur (acquired by Acelity).
Chief Operating Officer
Greg Liu has over 20 years of product development and operations experience. He was the founding R&D lead for a new Otology platform at Acclarent (acquired by J&J) and was a founding member of Verily Life Sciences, leading medical device strategic partnerships.
SENIOR Director of Marketing
Maureen Shay has over 15 years of healthcare experience, including 10+ of medical device marketing in both large and start-up organizations. Her experience spans all facets of physician and patient marketing.
Director of Engineering
Chris Pell has eight years of experience developing medical devices in a startup environment. He has developed a wide range of new products including interactive education technologies, an LED based bicycle lighting system and small extremity orthopedic implants.
Adam Martos has 4 years of experience developing early stage medical products in a startup environment. Adam was involved in development of an early-stage Mitral Valve repair product prior to Luma Therapeutics.
Jeff Sugarman, MD PhD
Chief Medical Officer
Jeff Sugarman, MD Phd is Assistant Clinical Professor in the Department of Dermatology at UCSF. He is board-certified in both pediatrics and dermatology and has published many articles on topics ranging from cancer research to childhood eczema.
Matt Likens is currently CEO of GT Medical Technologies, having previous lead Ulthera to over $100M in revenue and a $600M exit. His prior experience includes 5 years as President of GMP Wireless Medical and a 23 year career at Baxter.
John MacMahon is currently CEO of Mitre Medical Corp having previously led Kerberos Proximal Solutions (acquired by Fox Hollow Technologies). He has held leadership positions at Maya Medical (acquired by Covidien) and Claret Medical.
Alina Bridges, DO
DERMATOLOGIST AT MAYO CLINIC
HEAD OF MEDICAL TECHNOLOGIES
AT KCK GROUP
SENIOR VP LIVONGO HEALTH
WOULD YOU LIKE TO LEARN MORE ABOUT LUMA THERAPEUTICS?